Posts with tag Pharmaceuticals

Sort by Latest
Increased interest in the use of psychedelics as mainstream therapies
 ul { list-style-type: disc; padding-left: 40px; } ol { list-style-type: decimal; padding-left: 40px; } Psychedelics have been under investigation by academics, clinicians and pharmaceutical companies for some time and the momentum and interest in this area show no sign of slowing down. In this article we take a look at the latest initiative in the US and the current state of play in a number of other countries, including the UK. Background Psychedelics are defined...
July 4, 2023
6 min read
Revamping the European pharmaceutical industry: A closer...
On 26 April 2023, the European Commission published the long-anticipated...
April 28, 2023
3 min read
The Netherlands: Tolerance policy on online prescribing...
On 11 April 2023, the Dutch Ministry of Health, Welfare and Sport...
April 24, 2023
3 min read
The Legal 500: Pharmaceutical Advertising Comparative Guide 2022
The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The...
December 12, 2022
1 min read
Rebranding generics as branded medicines – CJEU issues new guidance
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with...
December 9, 2022
5 min read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders....
November 22, 2022
8 min read
The Second Draft Patent Examination Guidelines on Patent Linkage Invalidation, PTE and PTA
TTThe second draft amendment to the Patent Examination Guidelines (the “
November 3, 2022
4 min read
Publication of the English version of the new French Clinical Trial Agreement templates
The French legislator recently updated the French clinical trial agreement template also called...
October 10, 2022
2 min read